Scientific article
Immunocompromised patients have been neglected in COVID-19 trials: a call for action
ContributorsTrøseid, Marius; Hentzien, Maxime
Published inClinical microbiology and infection, vol. 28, no. 9, p. 1182-1183
Publication date2022-09
First online date2022-05-25
Keywords
- Antivirals
- COVID-19
- Guidelines
- Immunocompromised
- Trials
- Humans
- Immunocompromised Host
- SARS-CoV-2
Affiliation entities
Research groups
Funding
- European Commission - European Research and Preparedness Network for Pandemics and Emerging Infectious Diseases [101015736]
Citation (ISO format)
TRØSEID, Marius et al. Immunocompromised patients have been neglected in COVID-19 trials: a call for action. In: Clinical microbiology and infection, 2022, vol. 28, n° 9, p. 1182–1183. doi: 10.1016/j.cmi.2022.05.005
Main files (1)
Article (Published version)
Identifiers
- PID : unige:173267
- DOI : 10.1016/j.cmi.2022.05.005
- PMID : 35623577
- PMCID : PMC9130310
Additional URL for this publicationhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130310/
Journal ISSN1198-743X
